You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 5, May 1978 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (536)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Origin of Familial Malignant Melanomas From Heritable Melanocytic Lesions

`The B-K Mole Syndrome'

Wallace H. Clark, Jr, MD; Ronald R. Reimer, MD; Mark Greene, MD; Ann M. Ainsworth, MD; Michael J. Mastrangelo, MD

Arch Dermatol. 1978;114(5):732-738.


Abstract

• Distinctive melanocytic moles are described in 37 patients from six melanoma families. Among the family members examined by the authors, 15 of 17 patients with melanoma and 22 of 41 nonmelanoma relatives had the unique moles. The clinical and histological features of these moles have been designated the "B-K mole syndrome." The clinical features of the syndrome include the presence of < 10 to > 100 moles prominent on the upper trunk and extremities, and variability of mole size (5 mm to 15 mm), outline, and color combination. Histologically, B-K moles show atypical melanocytic hyperplasia, lymphocytic infiltration, delicate fibroplasia, and new blood vessels that occur within a compound nevus or de novo. The transformation of two B-K moles into malignant melanomas was documented photographically.

(Arch Dermatol 114:732-738, 1978)



Author Affiliations

From the Departments of Pathology and Dermatology, and the Fels Research Institute, Temple University School of Medicine, Philadelphia (Drs Clark and Ainsworth); the Environmental Epidemiology Branch, National Cancer Institute, Bethesda, Md (Drs Reimer and Greene); and the Fox Chase Cancer Center, Philadelphia (Dr Mastrangelo).


Footnotes

Accepted for publication Nov 16, 1977.

Presented at the American Academy of Dermatology, Dec 8, 1976.

Reprint requests to Department of Dermatology, Hospital of the University of Pennsylvania, 36th and Spruce St, Philadelphia, PA 19104 (Dr Clark).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Monitoring of Kindreds With Hereditary Predisposition for Cutaneous Melanoma and Dysplastic Nevus Syndrome: Results of a Swedish Preventive Program
Hansson et al.
JCO 2007;25:2819-2824.
ABSTRACT | FULL TEXT  

Nevus Type in Dermoscopy Is Related to Skin Type in White Persons
Zalaudek et al.
Arch Dermatol 2007;143:351-356.
ABSTRACT | FULL TEXT  

Morphologic changes of acquired melanocytic nevi with eccentric foci of hyperpigmentation ("Bolognia sign") assessed by dermoscopy.
Pizzichetta et al.
Arch Dermatol 2006;142:479-483.
ABSTRACT | FULL TEXT  

Grading melanocytic dysplasia in paraffin wax embedded tissue by the nucleic acid index
Berman et al.
J. Clin. Pathol. 2005;58:1206-1210.
ABSTRACT | FULL TEXT  

Population-Based Analysis of Prognostic Factors and Survival in Familial Melanoma
Florell et al.
JCO 2005;23:7168-7177.
ABSTRACT | FULL TEXT  

Melanocytic dysplastic naevi occupy the middle ground between benign melanocytic naevi and cutaneous malignant melanomas: emerging clues
Hussein
J. Clin. Pathol. 2005;58:453-456.
ABSTRACT | FULL TEXT  

Management of Cutaneous Melanoma
Tsao et al.
NEJM 2004;351:998-1012.
FULL TEXT  

Dysplastic Nevi
Naeyaert and Brochez
NEJM 2003;349:2233-2240.
FULL TEXT  

Pancreatic Carcinoma Surveillance in Patients With Familial Melanoma
Parker et al.
Arch Dermatol 2003;139:1019-1025.
ABSTRACT | FULL TEXT  

Ocular Melanoma: A Review and the Relationship to Cutaneous Melanoma
Hurst et al.
Arch Dermatol 2003;139:1067-1073.
ABSTRACT | FULL TEXT  

Analysis of Heterogeneity of Atypia Within Melanocytic Nevi
Barr et al.
Arch Dermatol 2003;139:289-292.
ABSTRACT | FULL TEXT  

Geographical Variation in the Penetrance of CDKN2A Mutations for Melanoma
Bishop et al.
JNCI J Natl Cancer Inst 2002;94:894-903.
ABSTRACT | FULL TEXT  

Molecular Aspects of Melanocytic Dysplastic Nevi
Hussein and Wood
J. Mol. Diagn. 2002;4:71-80.
ABSTRACT | FULL TEXT  

Dermoscopic Classification of Atypical Melanocytic Nevi (Clark Nevi)
Hofmann-Wellenhof et al.
Arch Dermatol 2001;137:1575-1580.
ABSTRACT | FULL TEXT  

Tumor Screening and Biology in Malignant Melanomas
Pozo and Diaz-Cano
Arch Dermatol 2000;136:934-935.
FULL TEXT  

Patterns of familial aggregation of three melanoma risk factors: great number of naevi, light phototype and high degree of sun exposure
Briollais et al.
Int J Epidemiol 2000;29:408-415.
ABSTRACT | FULL TEXT  

Genetics of Risk Factors for Melanoma: an Adult Twin Study of Nevi and Freckles
Bataille et al.
JNCI J Natl Cancer Inst 2000;92:457-463.
ABSTRACT | FULL TEXT  

CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia
Ruiz et al.
J. Med. Genet. 1999;36:490-493.
ABSTRACT | FULL TEXT  

The Atypical-Mole Syndrome and Predisposition to Melanoma
Wachsmuth et al.
NEJM 1998;339:348-349.
FULL TEXT  

Clinical crossroads: a young light-skinned woman with multiple moles.
Goldstein et al.
JAMA 1998;279:837-838.
FULL TEXT  

Nonpigmented Dysplastic Melanocytic Nevi
Knoell et al.
Arch Dermatol 1997;133:992-994.
ABSTRACT  

Interobserver Variability in Dermatopathology
Cramer
Arch Dermatol 1997;133:1033-1036.
ABSTRACT  

Clinically Recognized Dysplastic Nevi: A Central Risk Factor for Cutaneous Melanoma
Tucker et al.
JAMA 1997;277:1439-1444.
ABSTRACT  

Malignant Melanoma in Children: A Review
Ruiz-Maldonado and de la Luz Orozco-Covarrubias
Arch Dermatol 1997;133:363-371.
ABSTRACT  

Comparison Between Familial and Nonfamilial Melanoma in France
Grange et al.
Arch Dermatol 1995;131:1154-1159.
ABSTRACT  

Melanoma in Children
Ceballos et al.
NEJM 1995;332:656-662.
FULL TEXT  

Risk of Cutaneous Malignant Melanoma in Patients With 'Classic' Atypical-Mole Syndrome: A Case-Control Study
Marghoob et al.
Arch Dermatol 1994;130:993-998.
ABSTRACT  

Melanoma Risk in Individuals With Clinically Atypical Nevi
Kang et al.
Arch Dermatol 1994;130:999-1001.
ABSTRACT  

Controlling Malignant Melanoma: A Focus on Pediatricians
Brodkin and Altman
Arch Pediatr Adolesc Med 1993;147:875-881.
ABSTRACT  

Five Cases of Coexistent Primary Ocular and Cutaneous Melanoma
Bataille et al.
Arch Dermatol 1993;129:198-201.
ABSTRACT  

Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22
Cannon-Albright et al.
Science 1992;258:1148-1152.
ABSTRACT  

The Surgeon, Genetics, and Malignant Melanoma
LYNCH and FUSARO
Arch Surg 1992;127:317-320.
ABSTRACT  

Dysplastic Nevi: Occurrence in First- and Second-Degree Relatives of Patients With `Sporadic' Dysplastic Nevus Syndrome
Crijns et al.
Arch Dermatol 1991;127:1346-1351.
ABSTRACT  

Dysplastic Nevi as Risk Markers of Sporadic (Nonfamilial) Melanoma: A Case-Control Study
Halpern et al.
Arch Dermatol 1991;127:995-999.
ABSTRACT  

Frequency of Dysplastic Nevi Among Nevomelanocytic Lesions Submitted for Histopathologic Examination: Time Trends Over a 37-Year Period
Barnhill et al.
Arch Dermatol 1990;126:463-465.
ABSTRACT  

Origin of Cutaneous Melanoma in a Congenital Dysplastic Nevus Spilus
Rhodes and Mihm
Arch Dermatol 1990;126:500-505.
ABSTRACT  

A Hypothesis Incorporating the Histologic Characteristics of Dysplastic Nevi Into the Normal Biological Development of Melanocytic Nevi
Piepkorn
Arch Dermatol 1990;126:514-518.
ABSTRACT  

Dysplastic Melanocytic Nevi: Normal Variants or Melanoma Precursors?
Murphy and Halpern
Arch Dermatol 1990;126:519-522.
ABSTRACT  

Cutaneous Malignant Melanoma in Survivors of Heritable Retinoblastoma
Traboulsi et al.
Arch Ophthalmol 1988;106:1059-1061.
ABSTRACT  

Dysplastic Nevus Syndrome
Welkovich et al.
Arch Dermatol 1987;123:1280-1280.
ABSTRACT  

The Natural History of Dysplastic Nevi: A Case History Illustrating Their Evolution
Barnes and Nordlund
Arch Dermatol 1987;123:1059-1061.
ABSTRACT  

Dysplastic Nevus in Histologic Contiguity With Acquired Nonfamilial Melanoma: Clinicopathologic Experience in a 100-Bed Hospital
Duray and Ernstoff
Arch Dermatol 1987;123:80-84.
ABSTRACT  

Estrogen and Progesterone Receptors in Melanocytic Lesions: Occurrence in Patients With Dysplastic Nevus Syndrome
Ellis et al.
Arch Dermatol 1985;121:1282-1285.
ABSTRACT  

High Risk of Malignant Melanoma in Melanoma-Prone Families with Dysplastic Nevi
GREENE et al.
ANN INTERN MED 1985;102:458-465.
ABSTRACT  

Acquired Dysplastic Melanocytic Nevi and Cutaneous Melanoma: Precursors and Prevention
RHODES
ANN INTERN MED 1985;102:546-548.
ABSTRACT  

Precursors to Malignant Melanoma: Congenital and Dysplastic Nevi
Arndt
JAMA 1984;251:1882-1883.
ABSTRACT  

For the Record: The History of Precursors to Malignant Melanoma
Greene et al.
Arch Dermatol 1984;120:18-20.
ABSTRACT  

Target Blue Nevus
Bondi et al.
Arch Dermatol 1983;119:919-920.
ABSTRACT  

Familial Atypical Multiple Mole Melanoma Syndrome (FAMMM)
Fusaro et al.
Arch Dermatol 1983;119:2-3.
ABSTRACT  

Dermatology: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers
ANN INTERN MED 1983;98:117-118.
ABSTRACT  

Sporadic Atypical Mole Syndrome: A Report of Five Nonfamilial B-K Mole Syndrome-like Cases and Histopathologic Findings
Rahbari and Mehregan
Arch Dermatol 1981;117:329-331.
ABSTRACT  

Conjunctival Melanoma-Reply
Jakobiec
Arch Ophthalmol 1981;99:513-516.
ABSTRACT  

Topical Chemotherapy of Dysplastic Melanocytic Nevi With 5% Fluorouracil
Bondi et al.
Arch Dermatol 1981;117:89-92.
ABSTRACT  

Occupational Clustering of Melanoma
Aldrich and Nash
Arch Dermatol 1981;117:1-2.
ABSTRACT  

Levodopa Administration and Multiple Primary Cutaneous Melanomas
Bernstein et al.
Arch Dermatol 1980;116:1041-1044.
ABSTRACT  

Conjunctival Melanoma: Unfinished Business
Jakobiec
Arch Ophthalmol 1980;98:1378-1384.
ABSTRACT  

B-K Mole Syndrome: Cutaneous and Ocular Malignant Melanoma
Abramson et al.
Arch Ophthalmol 1980;98:1397-1399.
ABSTRACT  

Individual Differences in Cancer Susceptibility
HARRIS et al.
ANN INTERN MED 1980;92:809-825.
ABSTRACT  

Growth Dynamics of Malignant Melanomas: A Photodocumentary Investigation
Paul
Arch Dermatol 1980;116:182-185.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.